BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28841379)

  • 1. New Mandelalides Expand a Macrolide Series of Mitochondrial Inhibitors.
    Nazari M; Serrill JD; Wan X; Nguyen MH; Anklin C; Gallegos DA; Smith AB; Ishmael JE; McPhail KL
    J Med Chem; 2017 Sep; 60(18):7850-7862. PubMed ID: 28841379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Mandelalide E and Determinants of Cytotoxicity for the Mandelalide Series.
    Nazari M; Serrill JD; Sikorska J; Ye T; Ishmael JE; McPhail KL
    Org Lett; 2016 Mar; 18(6):1374-7. PubMed ID: 26914981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptolidin, a selective cytotoxic agent, is an inhibitor of F0F1-ATPase.
    Salomon AR; Voehringer DW; Herzenberg LA; Khosla C
    Chem Biol; 2001 Jan; 8(1):71-80. PubMed ID: 11182320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facile synthetic access to and biological evaluation of the macrocyclic core of apoptolidin.
    Wender PA; Jankowski OD; Tabet EA; Seto H
    Org Lett; 2003 Jun; 5(13):2299-302. PubMed ID: 12816433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mandelalides A-D, cytotoxic macrolides from a new Lissoclinum species of South African tunicate.
    Sikorska J; Hau AM; Anklin C; Parker-Nance S; Davies-Coleman MT; Ishmael JE; McPhail KL
    J Org Chem; 2012 Jul; 77(14):6066-75. PubMed ID: 22712890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Marine-Derived Macrolactone Mandelalide A Is an Indirect Activator of AMPK.
    Mattos DR; Wan X; Serrill JD; Nguyen MH; Humphreys IR; Viollet B; Smith AB; McPhail KL; Ishmael JE
    Mar Drugs; 2022 Jun; 20(7):. PubMed ID: 35877711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic Access to the Mandelalide Family of Macrolides: Development of an Anion Relay Chemistry Strategy.
    Nguyen MH; Imanishi M; Kurogi T; Wan X; Ishmael JE; McPhail KL; Smith AB
    J Org Chem; 2018 Apr; 83(8):4287-4306. PubMed ID: 29480727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cruentaren, a new antifungal salicylate-type macrolide from Byssovorax cruenta (myxobacteria) with inhibitory effect on mitochondrial ATPase activity. Fermentation and biological properties.
    Kunze B; Steinmetz H; Höfle G; Huss M; Wieczorek H; Reichenbach H
    J Antibiot (Tokyo); 2006 Oct; 59(10):664-8. PubMed ID: 17191683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Drugs Targeting the c-Ring of the F1FO-ATP Synthase.
    Pagliarani A; Nesci S; Ventrella V
    Mini Rev Med Chem; 2016; 16(10):815-24. PubMed ID: 26864551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profile of the selective mitochondrial F1F0 ATP hydrolase inhibitor BMS-199264 in myocardial ischemia.
    Grover GJ; Malm J
    Cardiovasc Ther; 2008; 26(4):287-96. PubMed ID: 19035880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptolidins A and C activate AMPK in metabolically sensitive cell types and are mechanistically distinct from oligomycin A.
    Serrill JD; Tan M; Fotso S; Sikorska J; Kasanah N; Hau AM; McPhail KL; Santosa DA; Zabriskie TM; Mahmud T; Viollet B; Proteau PJ; Ishmael JE
    Biochem Pharmacol; 2015 Feb; 93(3):251-65. PubMed ID: 25511868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total Synthesis, Stereochemical Revision, and Biological Reassessment of Mandelalide A: Chemical Mimicry of Intrafamily Relationships.
    Willwacher J; Heggen B; Wirtz C; Thiel W; Fürstner A
    Chemistry; 2015 Jul; 21(29):10416-30. PubMed ID: 26094957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzodiazepine-based selective inhibitors of mitochondrial F1F0 ATP hydrolase.
    Hamann LG; Ding CZ; Miller AV; Madsen CS; Wang P; Stein PD; Pudzianowski AT; Green DW; Monshizadegan H; Atwal KS
    Bioorg Med Chem Lett; 2004 Feb; 14(4):1031-4. PubMed ID: 15013017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-x
    Pfeiffer A; Schneider J; Bueno D; Dolga A; Voss TD; Lewerenz J; Wüllner V; Methner A
    Free Radic Biol Med; 2017 Nov; 112():350-359. PubMed ID: 28807815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A passive function of mitochondrial ATP synthase: target for tumor killer HAMLET.
    Boekema EJ
    J Mol Biol; 2015 May; 427(10):1863-5. PubMed ID: 25754830
    [No Abstract]   [Full Text] [Related]  

  • 16. Toward a stable apoptolidin derivative: identification of isoapoptolidin and selective deglycosylation of apoptolidin.
    Pennington JD; Williams HJ; Salomon AR; Sulikowski GA
    Org Lett; 2002 Oct; 4(22):3823-5. PubMed ID: 12599468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene expression during apoptosis induced by a serum factor: role of mitochondrial F0-F1 ATP synthase complex.
    Singh S; Khar A
    Apoptosis; 2005 Dec; 10(6):1469-82. PubMed ID: 16215688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoapoptolidin: structure and activity of the ring-expanded isomer of apoptolidin.
    Wender PA; Gulledge AV; Jankowski OD; Seto H
    Org Lett; 2002 Oct; 4(22):3819-22. PubMed ID: 12599467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of F1 epsilon subunit decreases mitochondrial content of ATP synthase and leads to accumulation of subunit c.
    Havlícková V; Kaplanová V; Nůsková H; Drahota Z; Houstek J
    Biochim Biophys Acta; 2010; 1797(6-7):1124-9. PubMed ID: 20026007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitors.
    Issaq SH; Teicher BA; Monks A
    Cell Cycle; 2014; 13(7):1152-61. PubMed ID: 24553119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.